Neuromodulation Through Multisensory Stimulation for Visual Field Deficits in the Subacute Stage of Disease

Recruiting N/A Interventional Study
Homonymous Hemianopsia Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
48 (estimated)
Sponsor
Istituto Auxologico Italiano · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Homonymous visual field defects (HVFDs) after acquired brain injuries affect daily life by impairing reading, navigation, and social activities, often impacting anxiety and depression. Spontaneous recovery is rare. Rehabilitation approaches include restorative treatments, which aim to expand the visual field through the stimulation of the so-called transition zone, and compensatory strategies, suc…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: \- Presence of subacute acquired brain injury (\< 3 months) with HVFD according to Neurophthalmological evaluation Exclusion Criteria: * Presence of hemispatial neglect (indexed by pathological asymmetries on paper-and-pencil tests) * Disorders of conjugated eye movements * Ot…
Contacts

Nadia Bolognini, PhD

02619116127

n.bolognini@auxologico.it

CONTACT